In Pursuit of Clinical Remission: Optimizing the Pharmacologic Management of Rheumatoid Arthritis

In Pursuit of Clinical Remission: Optimizing the Pharmacologic Management of Rheumatoid Arthritis is organized by Med Learning Group and will be held from Feb 25, 2019 - Feb 25, 2020. This CME Conference has been approved for a maximum of 1.25 AMA Category 1 Credit(s)™.

Target Audience:
This activity is designed to meet the educational needs of primarily rheumatologists with a secondary audience of internists and allied healthcare professionals involved in the care of patients with rheumatoid arthritis.

Description:
This enduring activity is focused on use of biologics and targeted therapies in the management of rheumatoid arthritis.

Learning Objectives:
Upon completion of this activity, participants will be able to:
• Describe the role of inflammatory cytokines, both articularly and systemically, in the pathogenesis of rheumatoid arthritis
• Review the clinical trials data supporting the medical society pharmacologic recommendations for patients with moderate-to-severe rheumatoid arthritis
• Discuss the use of interleukin-6 inhibition as a treat-to-target strategy in patients with moderate-to-severe RA

 Additional details will be posted as soon as they are available.